Non-Dividend Paying REIT and Leading Small-Cap Closed-End Fund Witness Mild Insider Buying, Plus Other Insider Transactions

EVP of Global Adhesives Provider Discards Shares

One member of HB Fuller Co (NYSE:FUL)’s management team offloaded a sizeable block of shares last week. James R. Giertz, Executive Vice President of Strategy, liquidated 25,000 shares on Friday at prices varying from $46.00 to $46.37 per shares. After the recent sale, Mr. Giertz currently holds a direct ownership stake of 58,121 shares.

The shares of the global adhesives provider are 24% in the green thus far in 2016. In late September, analysts at Citi initiated coverage on HB Fuller Co (NYSE:FUL) with a ‘Buy’ rating and a price target of $53. Citi analysts expect the second-largest global adhesives company to achieve earnings growth through portfolio expansion, a profitability turnaround in Europe, as well as optionality from merger and acquisition activities. “We like FUL’s portfolio shift toward both higher growth and margins in engineering adhesives,” an effort supported by the acquisition of Chinese engineering adhesives company Tonsan in February of 2015. Alyeska Investment Group, founded by Annand Parekh, had 374,188 shares of HB Fuller Co (NYSE:FUL) in its portfolio at the end of June.

Notable Insider Selling at Low-Priced Supplier of Semiconductor Test and Burn-In Equipment

Two corporate insiders at Aehr Test Systems (NASDAQ:AEHR) sold some shares last week. To start with, President and Chief Executive Officer Gayn Erickson discarded 7,000 shares on Thursday and 3,000 shares on Friday at prices that fell between $2.70 and $2.87 per share. The CEO currently owns 342,694 shares. Rhea J. Posedel, the founder of Aehr Test Systems and Chairman of its Board of Directors since March 2013, sold 1,925 shares last Tuesday at prices ranging from $3.09 to $3.20 per share. The shares were held in a trust fund that currently owns 989,364 shares.

The supplier of semiconductor test and burn-in equipment has seen its market value gain 42% in 2016. Aehr Test Systems (NASDAQ:AEHR)’s net sales primarily consist of sales of systems, test fixtures, die carriers, upgrades and spare parts, as well as revenues from service contracts. The company’s net sales for the three months that ended August 31 were $5.3 million, down from $6.6 million recorded a year ago. Nonetheless, the company recorded an impressive $10.4 million in bookings for the first quarter of fiscal 2017. Ken Griffin’s Citadel Advisors LLC acquired a new stake of 12,012 shares in Aehr Test Systems (NASDAQ:AEHR) during the April-to-June quarter.

Disclosure: None